None listed
Conditions
Interventions
Medical Device : 1. Both the intervention and control group
Participants’ brain magnetic resonance imaging (MRI) data will be analyzed using NEUROPHET tES LAB to derive individualized, customized stim
Sponsors
Neurophet
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Adult men and women aged 19 years or older. 2) Patients with a diagnosis of stroke confirmed by brain imaging. 3) Patients with subacute stroke within 2 weeks to 3 months after stroke onset. 4) Patients with unilateral upper-limb paralysis.
Exclusion criteria
Exclusion criteria: 1. Patients with a history of diseases that have affected function of the paretic upper limb. 2. Patients who are not eligible for tDCS, including: those with scalp diseases or metallic materials at the tDCS electrode placement sites; those with implanted cardiac pacemakers or cochlear implants. 3. Patients with medical contraindications to brain imaging (MRI). 4. Pregnant or breastfeeding women, or women planning to become pregnant during the study period. 5. Patients who are deemed inappropriate for participation in this clinical study based on medical or ethical considerations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Fugl-Meyer Assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Fugl-Meyer Assessment | — |
Countries
Korea, Republic of
Contacts
Public ContactSoyoung Park
Yonsei University Health System, Severance Hospital
Outcome results
None listed